Daiichi Sankyo Co., 第一三共

[link|183|Daiichi Sankyo website] is a pharmaceutical company with headquarters in Tokyo. Daiichi Sankyo is a merger of Sankyo Co. and Daiichi Pharmaceutical Co., finalized in 2007. The focus is on R and D, manufacturing, import, and sales/marketing of pharmaceutical products. Sales of Daiichi Sankyo are in the order of 950 billion Yen (~ 8,5 billion €). Daiichi Sankyo has ~ 30.000 employees. Capital is 50 billion yen (~ 450 million €). Chairman is Mr Takashi SHODA, CEO is Mr Yoji NAKAYAMA.

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny